Approved for Empirical therapy for presumed fungal infections in febrile neutropenic patients, Invasive candidiasis including candidemia, Invasive aspergillosis in patients refractory to or intolerant of other therapies. Inhibits the synthesis of beta-(1,3)-D-glucan, an essential component of the fungal cell wall not present in mammalian cells. This disrupts cell wall integrity, leading to…
Loading full data from Know Your Drugs Institute…